CSRIX
Price
$54.59
Change
+$0.25 (+0.46%)
Updated
Jul 13 closing price
Net Assets
8.99B
HLRRX
Price
$9.90
Change
-$0.01 (-0.10%)
Updated
Jul 13 closing price
Net Assets
30.24M
Interact to see
Advertisement

CSRIX vs HLRRX

CSRIX vs HLRRX Comparison Chart in %
View a ticker or compare two or three
VS
CSRIX vs. HLRRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSRIX is a StrongBuy and HLRRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSRIX has more cash in the bank: 8.99B vs. HLRRX (30.2M). CSRIX pays higher dividends than HLRRX: CSRIX (2.75) vs HLRRX (2.39). CSRIX was incepted earlier than HLRRX: CSRIX (26 years) vs HLRRX (24 years). HLRRX (2.82) is less costly to investors than CSRIX (0.76). HLRRX is a more actively managed with annual turnover of: 85.95 vs. CSRIX (33.00). HLRRX has a lower initial minimum investment than CSRIX: HLRRX (10000) vs CSRIX (1000000). CSRIX annual gain was more profitable for investors over the last year : 13.84 vs. HLRRX (2.36). CSRIX return over 5 years is better than : 17.34 vs. HLRRX (-23.54).
CSRIXHLRRXCSRIX / HLRRX
Total Expense Ratio0.751.5548%
Annual Report Gross Expense Ratio0.762.8227%
Fund Existence26 years24 years-
Gain YTD15.67414.802106%
Front LoadN/AN/A-
Min. Initial Investment10000001000010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.99B30.2M29,755%
Annual Yield % from dividends2.752.39115%
Returns for 1 year13.842.36586%
Returns for 3 years31.465.87536%
Returns for 5 years17.34-23.54-74%
Returns for 10 years46.85-23.72-198%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCIIX20.52N/A
N/A
Goldman Sachs Intl Eq Insghts Instl
GRMAX33.75N/A
N/A
Nationwide S&P 500 Index A
VBCVX17.87N/A
N/A
VALIC Company I Systematic Value
IASCX13.94N/A
N/A
Voya Small Company Port A
RYMDX166.43N/A
N/A
Rydex Mid-Cap 1.5x Strategy H